Prior statin use and 90-day mortality in Gram-negative and Gram-positive bloodstream infection: a prospective observational study

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 34, Issue 3, 2015, Pages 609-617

  Mehl, A ^a,b   Harthug, S ^c,d   Lydersen, S ^b   Paulsen, J ^a,b   Asvold B O ^b,e   Solligard E ^b,e   Damas J K ^b,e   Edna, T H ^a,b  

^a Nord Trondelag Hospital Trust Levanger   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF BERGEN   (Norway)

^e TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT;

ADULT; AGED; ALPHA HEMOLYTIC STREPTOCOCCUS; ANAEROBIC BACTERIUM; ANTIBIOTIC THERAPY; ARTICLE; BETA HEMOLYTIC STREPTOCOCCUS; BLOODSTREAM INFECTION; CARDIOVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX; COAGULASE NEGATIVE STAPHYLOCOCCUS; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG USE; ENTEROBACTER; ENTEROBACTERIACEAE INFECTION; ENTEROCOCCAL INFECTION; ENTEROCOCCUS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; FUNCTIONAL STATUS; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INNATE IMMUNITY; KLEBSIELLA; KLEBSIELLA INFECTION; LISTERIA MONOCYTOGENES; LISTERIOSIS; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; MORTALITY; NEISSERIA MENINGITIDIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEUS; PROTEUS INFECTION; PSEUDOMONAS; PSEUDOMONAS INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS VIRIDANS INFECTION; VERY ELDERLY; MICROBIOLOGY; MIDDLE AGED; SEPSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTICHOLESTEREMIC AGENTS; COHORT STUDIES; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEPSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84941740268     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2269-6     Document Type: Article

References (36)

1. Goto M, Al-Hasan MN (2013) Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect 19(6):501–509
2. Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348(16):1546–1554
3. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29(7):1303–1310
4. Liappis AP, Kan VL, Rochester CG, Simon GL (2001) The effect of statins on mortality in patients with bacteremia. Clin Infect Dis 33(8):1352–1357
5. Kruger P, Fitzsimmons K, Cook D, Jones M, Nimmo G (2006) Statin therapy is associated with fewer deaths in patients with bacteraemia. Intensive Care Med 32(1):75–79
6. Hsu J, Andes DR, Knasinski V, Pirsch J, Safdar N (2009) Statins are associated with improved outcomes of bloodstream infection in solid-organ transplant recipients. Eur J Clin Microbiol Infect Dis 28(11):1343–1351
7. Thomsen RW, Hundborg HH, Johnsen SP, Pedersen L, Sørensen HT, Schønheyder HC, Lervang HH (2006) Statin use and mortality within 180 days after bacteremia: a population-based cohort study. Crit Care Med 34(4):1080–1086
8. López-Cortés LE, Gálvez-Acebal J, Del Toro MD, Velasco C, de Cueto M, Caballero FJ, Muniain MA, Pascual A, Rodríguez-Baño J (2013) Effect of statin therapy in the outcome of bloodstream infections due to Staphylococcus aureus: a prospective cohort study. PLoS One 8(12):e82958
9. Viasus D, Gudiol C, Fernández-Sabé N, Cabello I, Garcia-Vidal C, Cisnal M, Duarte R, Antonio M, Carratalà J (2011) Effect of statins on outcomes in immunosuppressed patients with bloodstream infection. Eur J Clin Microbiol Infect Dis 30(1):77–82
10. Yang KC, Chien JY, Tseng WK, Hsueh PR, Yu CJ, Wu CC (2007) Statins do not improve short-term survival in an oriental population with sepsis. Am J Emerg Med 25(5):494–501
11. Leung S, Pokharel R, Gong MN (2012) Statins and outcomes in patients with bloodstream infection: a propensity-matched analysis. Crit Care Med 40(4):1064–1071
12. Opal SM, Cohen J (1999) Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis? Crit Care Med 27(8):1608–1616
13. Leaver SK, Finney SJ, Burke-Gaffney A, Evans TW (2007) Sepsis since the discovery of Toll-like receptors: disease concepts and therapeutic opportunities. Crit Care Med 35(5):1404–1410
14. Nolte FS, Williams JM, Jerris RC, Morello JA, Leitch CD, Matushek S, Schwabe LD, Dorigan F, Kocka FE (1993) Multicenter clinical evaluation of a continuous monitoring blood culture system using fluorescent-sensor technology (BACTEC 9240). J Clin Microbiol 31(3):552–557
15. Yende S, Milbrandt EB, Kellum JA, Kong L, Delude RL, Weissfeld LA, Angus DC (2011) Understanding the potential role of statins in pneumonia and sepsis. Crit Care Med 39(8):1871–1878
16. Cohen J, Guyatt G, Bernard GR, Calandra T, Cook D, Elbourne D, Marshall J, Nunn A, Opal S; UK Medical Research Council International Working Party (2001) New strategies for clinical trials in patients with sepsis and septic shock. Crit Care Med 29(4):880–886
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383
18. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ (2002) Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137(10):791–797
19. Shorr AF, Tabak YP, Killian AD, Gupta V, Liu LZ, Kollef MH (2006) Healthcare-associated bloodstream infection: a distinct entity? Insights from a large U.S. database. Crit Care Med 34(10):2588–2595
20. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G; International Sepsis Definitions Conference (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29(4):530–538
21. Vincent JL, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med 26(11):1793–1800
22. Rothman KJ (2012) Epidemiology: an introduction. Oxford University Press, Oxford
23. Thomsen RW, Riis A, Kornum JB, Christensen S, Johnsen SP, Sørensen HT (2008) Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients. Arch Intern Med 168(19):2081–2087
24. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, Martinez F, Marrie TJ, Plouffe JF, Ramirez J, Sarosi GA, Torres A, Wilson R, Yu VL; American Thoracic Society (2001) Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 163(7):1730–1754
25. Lydersen S, Langaas M, Bakke Ø (2012) The exact unconditional z-pooled test for equality of two binomial probabilities: optimal choice of the Berger and Boos confidence coefficient. J Stat Comput Simul 82(9):1311–1316
26. Majumdar SR, McAlister FA, Eurich DT, Padwal RS, Marrie TJ (2006) Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ 333(7576):999
27. Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG (2007) Statins and sepsis: multiple modifications at multiple levels. Lancet Infect Dis 7(5):358–368
28. Owens AP 3rd, Passam FH, Antoniak S, Marshall SM, McDaniel AL, Rudel L, Williams JC, Hubbard BK, Dutton JA, Wang J, Tobias PS, Curtiss LK, Daugherty A, Kirchhofer D, Luyendyk JP, Moriarty PM, Nagarajan S, Furie BC, Furie B, Johns DG, Temel RE, Mackman N (2012) Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin. J Clin Invest 122(2):558–568
29. Matsumoto M, Einhaus D, Gold ES, Aderem A (2004) Simvastatin augments lipopolysaccharide-induced proinflammatory responses in macrophages by differential regulation of the c-Fos and c-Jun transcription factors. J Immunol 172(12):7377–7384
30. Wu BQ, Luo JM, Wang YH, Shi YF, Liu H, Ba JH, Zhang TT (2014) Inhibitory effects of simvastatin on Staphylococcus aureus lipoteichoic acid-induced inflammation in human alveolar macrophages. Clin Experiment Med 14(2):151–160
31. Methe H, Kim JO, Kofler S, Nabauer M, Weis M (2005) Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes. Arterioscler Thromb Vasc Biol 25(7):1439–1445
32. Niessner A, Steiner S, Speidl WS, Pleiner J, Seidinger D, Maurer G, Goronzy JJ, Weyand CM, Kopp CW, Huber K, Wolzt M, Wojta J (2006) Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo. Atherosclerosis 189(2):408–413
33. Abe M, Matsuda M, Kobayashi H, Miyata Y, Nakayama Y, Komuro R, Fukuhara A, Shimomura I (2008) Effects of statins on adipose tissue inflammation: their inhibitory effect on MyD88-independent IRF3/IFN-beta pathway in macrophages. Arterioscler Thromb Vasc Biol 28(5):871–877
34. Papazian L, Roch A, Charles PE, Penot-Ragon C, Perrin G, Roulier P, Goutorbe P, Lefrant JY, Wiramus S, Jung B, Perbet S, Hernu R, Nau A, Baldesi O, Allardet-Servent J, Baumstarck K, Jouve E, Moussa M, Hraiech S, Guervilly C, Forel JM; STATIN-VAP Study Group (2013) Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial. JAMA 310(16):1692–1700
35. Kruger P, Bailey M, Bellomo R, Cooper DJ, Harward M, Higgins A, Howe B, Jones D, Joyce C, Kostner K, McNeil J, Nichol A, Roberts MS, Syres G, Venkatesh B; ANZ-STATInS Investigators–ANZICS Clinical Trials Group (2013) A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis. Am J Respir Crit Care Med 187(7):743–750
36. Kouroumichakis I, Papanas N, Proikaki S, Zarogoulidis P, Maltezos E (2011) Statins in prevention and treatment of severe sepsis and septic shock. Eur J Intern Med 22(2):125–133